NCT03040947

Brief Summary

The purpose of this study is to develop imaging protocols when using cardiovascular magnetic resonance (CMR) to assess cardiac functions, morphology and tissue characterization. The National Heart Research Institute Singapore (NHRIS) houses two dedicated CMR scanners to support the numerous investigator initiated projects in patients with various cardiac pathologists. By optimizing novel CMR sequences used in these studies, scanning time can be shortened for patients with underlying cardiac diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2016

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

January 31, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 2, 2017

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

March 3, 2021

Status Verified

June 1, 2020

Enrollment Period

6.8 years

First QC Date

January 31, 2017

Last Update Submit

March 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • First occurrence of cardiovascular event

    This outcomes are obtained via hospital records or by a phone follow-up

    1 day

Study Arms (2)

Healthy Volunteer

Healthy Volunteers will undergo a cardiovascular magnetic resonance imaging scan.

Other: Cardiovascular Magnetic Resonance

Diseased (Suspected or Known Cardiac Conditions)

Patients will undergo a cardiovascular magnetic resonance imaging scan.

Other: Cardiovascular Magnetic Resonance

Interventions

Diseased (Suspected or Known Cardiac Conditions)Healthy Volunteer

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Potential participants will be identified from an existing database of healthy volunteers who had previously participated in the biobank program and indicated interest in future studies. Potential patients are identified from the imaging or admissions databases. The primary physicians of these patients identified will be notified prior to recruitment and the patient will only be recruited if the primary physician is agreeable. Alternatively, other methods of participant identification include co-workers of the department who volunteer themselves and indicate on the Informed Consent Document that their participation was entirely voluntary and not under coercion. Team members of this study are not eligible for participation.

You may qualify if:

  • Has no known significant medical history
  • Is able to give informed consent

You may not qualify if:

  • Has contraindications to CMR implantable devices, cerebral aneutysm clips and cochlear implants
  • Has claustrophobia
  • Females who are pregnant
  • Is unable to comply with study protocols

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Heart Centre Singapore

Singapore, 169609, Singapore

RECRUITING

Related Publications (1)

  • Le TT, Bryant JA, Ting AE, Ho PY, Su B, Teo RC, Gan JS, Chung YC, O'Regan DP, Cook SA, Chin CW. Assessing exercise cardiac reserve using real-time cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2017 Jan 23;19(1):7. doi: 10.1186/s12968-017-0322-1.

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples will be collected from all participants before and after the CMR scan.

MeSH Terms

Conditions

Cardiomyopathy, HypertrophicCardiomyopathy, DilatedHypertrophy, Left VentricularMyocardial IschemiaHypertension

Condition Hierarchy (Ancestors)

CardiomyopathiesHeart DiseasesCardiovascular DiseasesAortic Stenosis, SubvalvularAortic Valve StenosisAortic Valve DiseaseHeart Valve DiseasesCardiomegalyLaminopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHypertrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsVascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2017

First Posted

February 2, 2017

Study Start

March 1, 2016

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

March 3, 2021

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations